BioSpace News Archive

Herpes Simplex Virus (HSV) Vaccines Market Insights | Global Industry Analysis – Forecast [2020-2030]

Herpes simplex virus vaccines help preventing the occurrence of herpes disease. The disease can mainly occur around mouth or genitals, and also on different parts of the body.

May 5, 2022
·
6 min read
Pouchitis Treatment Market: High incidence of pouchitis to drive the market

Albany NY, United States: Pouchitis is an inflammatory condition of the ileal pouch. It happens when the ileal pouch reservoir becomes inflamed or irritated.

May 5, 2022
·
7 min read
BioCapital

QIAGEN Adds HSV1/2 Herpes Assay With CE-IVD Certification for Use on NeuMoDx Integrated PCR System

QIAGEN N.V. announced that its NeuMoDx HSV 1/2 Quant Assay for the quantification and differentiation of herpes simplex virus type 1 DNA and/or herpes simplex virus type 2 has received CE-IVD certification for the European Union and other countries that accept this marking.

May 5, 2022
·
5 min read
Business

Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Quarter Results for 2022

Zealand Pharma A/S announced that it will host a conference call on May 12, 2022 at 4 pm CET following the announcement of results for the first quarter of 2022.

May 5, 2022
·
3 min read
Drug Development

Bavarian Nordic Reports Omicron Data from Phase 2 Trial of its COVID-19 Booster Vaccine Candidate

Bavarian Nordic A/S announced additional results from its Phase 2 clinical trial of ABNCoV2, a VLP-based, non-adjuvanted COVID-19 vaccine candidate.

May 5, 2022
·
4 min read
Business

AlzeCure Publishes its Interim Report for January – March 2022

AlzeCure Pharma AB announced that its interim report for the period January - March 2022 is now available on the company’s website.

May 5, 2022
·
4 min read
Business

Lexicon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical Update

Lexicon Pharmaceuticals, Inc., reported financial results for the three months ended March 31, 2022 and provided an update on key milestones.

May 5, 2022
·
6 min read
Business

Modivcare Reports First Quarter 2022 Financial Results

Modivcare Inc. today reported financial results for the three months ended March 31, 2022.

May 5, 2022
·
21 min read
Biotech Bay

Curebase Secures $40 Million in Series B Funding

Curebase has raised $40 million in Series B funding to continue development of its end-to-end clinical trial execution model, virtual and hybrid site capabilities, and full eClinical software platform to run modern, patient-centric clinical trials.

May 5, 2022
·
4 min read
Drug Development

Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-856 in Celiac Disease

Immunic, Inc. announced the start of the patient cohorts in its ongoing phase 1 clinical trial of IMU-856, the company’s third clinical asset, in patients with celiac disease.

May 5, 2022
·
9 min read